Showing 951-960 of 4590 results for "".
Natural Lip Rejuvenation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cohen-3/19207/Joel L. Cohen, MD, FAAD talks about the need to achieve natural results when treating the lips and explains the need to educate all patients about your "natural philosophy."Sequencing Therapies for Long-Term Control of Atopic Dermatitis
https://practicaldermatology.com/videos/dermatology-hub-neuroimmune-network/sequencing-therapies-for-long-term-control-of-atopic-dermatitis/48786/Christopher Bunick, MD, FAAD, talks about the six effective and safe advanced systemic therapies for atopic dermatitis and how to prescribe them for patients as early as possible by understanding the guidelines and the labels.Strategies for Gaining Prior Authorizations for AD Treatments
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/strategies-for-gaining-prior-authorizations-for-ad-treatments/57009/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, provides helpful tips for ensuring that insurance companies cover prescribed treatments for atopic dermatitis.SCALE 2024: Dr. Michael Gold Recaps the Show and Previews 2025
https://practicaldermatology.com/conferences/scale-2024/scale-2024-dr-michael-gold-recaps-show-and-previews-2025/26751/Michael Gold, MD, FAAD, Course Co-Director for Music City SCALE, discusses the growth of the event over the years, highlights from 2024, and what to expect next year.Beyond Skin Clearance: What Patient-Reported Outcomes Reveal in Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-updates-in-atopic-dermatitis/beyond-skin-clearance-what-patient-reported-outcomes-reveal-in-atopic-dermatitis/57286/Michael Lewitt, MD, FAAD, explains how patient-reported outcomes capture itch, sleep, pain, treatment experience, and other dimensions of atopic dermatitis that clinical measures may miss.GEP Testing for Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/videos/updates-in-skin-cancer/gep-testing-for-cutaneous-squamous-cell-carcinoma/35599/Emily Ruiz, MD, MPH, FAAD, director of the High-Risk Cancer Clinic at Dana-Farber Cancer Institute, discusses utilizing gene expression profiling (GEP) to risk stratify tumors in cutaneous squamous cell carcinoma patients.Retaliation Rules ... Without Rules
https://practicaldermatology.com/topics/editorial/retaliation-rules-without-rules/26653/Practical Dermatology Chief Medical Editor and dermatologist Neal Bhatia, MD, FAAD, reflects on the dynamics of medical board complaints, their impact on careers, and what pracitioners need to keep in mind when dealing with challenges.Differentiating Atopic Dermatitis From Psoriasis and CTCL
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/differentiating-atopic-dermatitis-from-psoriasis-and-ctcl/48778/Christopher Bunick, MD, FAAD, discusses the overlap in gene expression and cytokine signaling between atopic dermatitis and psoriasis, the possibility of CTCL mimicking atopic dermatitis, and the utility of a skin biopsy in some cases to differentiate.Analyzing Recent Deuruxolitinib Data
https://practicaldermatology.com/videos/skin-minute/analyzing-recent-deuruxolitinib-data/57165/Arash Mostaghimi, MD, MPH, FAAD, Vice Chair of Clinical Trials and Innovation for the Brigham & Women's Hospital Department of Dermatology, discusses reently released data on deuruxolitinib for the treatment of alopecia areata.The Emergence of Targeted Therapies for Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/the-emergence-of-targeted-therapies-for-prurigo-nodularis/48775/Christopher Bunick, MD, FAAD, discusses the importance of acknowledging prurigo nodularis as a distinct disease with its own molecular and transcriptomic features distinguishing it from atopic dermatitis, and how targeting the IL-31 receptor can change the game.